Jul 19, 2023

Ophthalmology Times: Cellular evidence of retinal ganglion cell transfection after LHON treatment

Video Transcript

Editor’s note – This transcript has been edited for clarity.

David Hutton:

I’m David Hutton of Ophthalmology Times. At its annual meeting earlier this year, the Association for Research in Vision and Ophthalmology, named Dr. SriniVas Sadda, president-elect of the organization. He joins us today to discuss his term, as well as his research work at the Doheny Eye Institute. Thanks for joining us. When you begin your term as president at the end of the 2024 annual meeting, what will you focus on?

SriniVas R. Sadda, MD:

Well, thanks very much, David, it’s been a great honor for me to be able to be selected and trusted by ARVO in the membership and this role. I’ve been attending ARVO board meetings since 1992. So I’m really a veteran of ARVO.

Really, you know, my role in terms of president is really to facilitate the great work of the tremendous team that we have the entire board of trustees, and the staff at ARVO who do a tremendous job of not only organizing our meeting, but all of the other activities that ARVO supports.

Read more >


Share this with your friends!